Literature DB >> 10916281

Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome.

B da Sliva1, S M Gapstur, Y H Achenbach, T S Schuh, T J Kotlar, K Liu, W L Lowe.   

Abstract

BACKGROUND: Previous studies have demonstrated a role for tumor necrosis factor-alpha (TNF-alpha) in insulin resistance. A polymorphic variant of the TNF-alpha gene, the TNF2 allele, which is a guanine to adenine polymorphism at position -308 in the TNF-alpha promoter, is associated with higher basal and inducible promoter activity. The present study examined whether the TNF2 allele was associated with altered levels of different components of the insulin resistance syndrome, clustering of these components, or the 10-year change in the level of these components.
METHODS: Components of the insulin resistance syndrome included insulin resistance, as determined by fasting insulin levels, body mass index, systolic blood pressure, triglycerides, uric acid, and high density lipoprotein-cholesterol. The study population was a subsample of participants from the Coronary Artery Risk Development in (Young) Adults (CARDIA) study, which included African American and white men and women aged 18-30. The sample included 243 black women, 142 black men, 392 white women, and 386 white men. Subjects were typed at the TNF-alpha locus.
RESULTS: The frequency of the TNF2 allele was 12% in blacks and 16% in whites. Age-adjusted levels of the different components examined were not different at either baseline or year 10 in carriers of the TNF2 allele versus homozygotes for the wild-type allele, and the 10-year change in the level of different components was not different between the two genotype groups. There also was no evidence of increased clustering of components of the insulin resistance syndrome in carriers of the TNF2 allele. Moreover, there was no evidence of an association between the TNF2 allele and clustering across quartiles of BMI or quartiles of dietary fat intake (i.e., Key's score).
CONCLUSIONS: In African Americans and whites, neither the TNF2 allele nor another polymorphism in the TNF-alpha gene or a neighboring gene with which the TNF2 allele is in linkage disequilibrium is associated with differences in the level of or increased clustering of components of the insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10916281

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  5 in total

1.  Assessment of 11-β hydroxysteroid dehydrogenase (11-βHSD1) 4478T>G and tumor necrosis factor-α (TNF-α)-308G>A polymorphisms with obesity and insulin resistance in Asian Indians in North India.

Authors:  Mukti Sharma; Naval Kishore Vikram; Anoop Misra; SuryaPrakash Bhatt; Mohammed Tarique; Hilal Ahmad Parray; Ravindra Mohan Pandey; Kalpana Luthra
Journal:  Mol Biol Rep       Date:  2013-11       Impact factor: 2.316

2.  Risk of obesity and type 2 diabetes with tumor necrosis factor-α 308G/A gene polymorphism in metabolic syndrome and coronary artery disease subjects.

Authors:  Ranbir Chander Sobti; Rupinder Kler; Yash Paul Sharma; Kewal Krishan Talwar; Neha Singh
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

3.  Polymorphisms for interleukin-4 (IL-4) -590 promoter, IL-4 intron3, and tumor necrosis factor alpha -308 promoter: non-association with endometriosis.

Authors:  Yao-Yuan Hsieh; Chi-Chen Chang; Fuu-Jen Tsai; Yuan Hsu; Horng-Der Tsai; Chang-Hai Tsai
Journal:  J Clin Lab Anal       Date:  2002       Impact factor: 2.352

4.  Influence of G308A polymorphism of tumor necrosis factor alpha gene on surgical results of biliopancreatic diversion.

Authors:  D A de Luis; D Pacheco; R Aller; M González Sagrado; O Izaola; M C Terroba; L Cuellar; R Conde; T Martin
Journal:  Obes Surg       Date:  2008-06-20       Impact factor: 4.129

5.  The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution.

Authors:  S Romeo; F Sentinelli; F Capici; M Arca; A Berni; E Vecci; U Di Mario; M G Baroni
Journal:  BMC Med Genet       Date:  2001-09-07       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.